Grace Therapeutics (GRCE) FCF Margin (2012 - 2026)
Grace Therapeutics (GRCE) recorded FCF Margin of -2284.40% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 1401.55 percentage points from -882.84% a year earlier and down 1056.14 percentage points from the prior quarter.
Grace Therapeutics (GRCE) FCF Margin (2012 - 2026) Analysis & Trends
On a TTM basis, Grace Therapeutics' FCF Margin came in at -1651.52% as of Jun 30, 2026, up 229.25 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -1294.74%, up 752.51 percentage points from FY2025.
- Annual FCF Margin has a five-year change of +6046.07 percentage points (FY2021 to FY2026).
- Across earlier fiscal years, FCF Margin came in at -2047.25% in FY2025 (-635.25 pp) and -1412.00% in FY2024.
- The fiscal Q1 2027 figure is the lowest quarterly FCF Margin since fiscal Q3 2025.
- On a year-over-year basis, FCF Margin rose in four of the last five quarters, with an average year-over-year change of +413.69 percentage points.
- Per Business Quant, the preceding three fiscal quarters came in at -1228.26% (Q4 2026), -1296.51% (Q3 2026) and -1827.33% (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 28.96% |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - | -1,158.44% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,284.40% |
| Mar 31, 2026 | -1,228.26% |
| Dec 31, 2025 | -1,296.51% |
| Sep 30, 2025 | -1,827.33% |
| Jun 30, 2025 | -882.84% |
| Mar 31, 2025 | -1,605.43% |
| Dec 31, 2024 | -3,240.16% |
| Sep 30, 2024 | -2,329.12% |
| Jun 30, 2024 | -1,530.21% |
| Mar 31, 2021 | -1,530.43% |
| Dec 31, 2020 | -5,202.47% |
| Mar 31, 2018 | -347.80% |
| Nov 30, 2016 | -65.24% |
| Aug 31, 2016 | -7,811.41% |
| May 31, 2016 | -54,016.62% |
| Nov 30, 2015 | -30,549.96% |
| Aug 31, 2015 | -32,501.19% |
| May 31, 2015 | -16,215.00% |
| Feb 28, 2015 | -1,473.24% |
| Nov 30, 2014 | -7,739.20% |
Grace Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();